205 4Fe-4S ferredoxin
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 33 | 8.2 | 4.01× | q < 0.0001 | |
| Benzenoids | 4 | 5.4 | 0.74× | q = 0.73 | |
| Homogeneous non-metal compounds | 10 | 15.9 | 0.63× | q = 0.17 | |
| Organoheterocyclic compounds | 7 | 11.4 | 0.61× | q = 0.26 | |
| Homogeneous metal compounds | 20 | 36.3 | 0.55× | q = 5.2e-4 | |
| Nucleosides, nucleotides, and analogues | 11 | 20.4 | 0.54× | q = 0.02 | |
| Organic acids and derivatives | 3 | 11.4 | 0.26× | q = 7.3e-3 | |
| Organic oxygen compounds | 2 | 14.7 | 0.14× | q < 0.0001 | |
| Organohalogen compounds | 2 | 0.2 | 9.49× | not tested | |
| Mixed metal/non-metal compounds | 2 | 1.6 | 1.29× | not tested | |
| Organic nitrogen compounds | 1 | 2.4 | 0.42× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 79 |
| DB03426 | DGD | Digalactosyl Diacyl Glycerol (Dgdg) | 61 |
| DB02832 | SRM | Siroheme | 48 |
| DB04327 | PEE | Phosphatidylethanolamine | 43 |
| DB03147 | FAD | Flavin adenine dinucleotide | 22 |
| DB18267 | HEM | Ferroheme | 11 |
| DB07349 | AGA | (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE | 8 |
| DB00172 | PRO | Proline | 7 |
| DB02078 | PG5 | Triglyme | 7 |
| DB03350 | NCO | Cobalt hexammine ion | 6 |
| DB13075 | MQ7 | Menaquinone 7 | 6 |
| DB00160 | ALA | Alanine | 4 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 4 |
| DB03247 | FMN | Flavin mononucleotide | 4 |
| DB16833 | ADP | Adenosine disphosphate | 4 |
| DB00149 | LEU | Leucine | 3 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 3 |
| DB00151 | CYS | Cysteine | 2 |
| DB00157 | — | NADH | 2 |
| DB01957 | 3CH | 3-Chlorophenol | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SF4 | IRON/SULFUR CLUSTER | 1,970 |
| Kmetal | POTASSIUM ION | 125 |
| F3S | FE3-S4 CLUSTER | 124 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 106 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 102 |
| MGmetal | MAGNESIUM ION | 76 |
| DGD | DIGALACTOSYL DIACYL GLYCEROL (DGDG) | 60 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 56 |
| CAmetal | CALCIUM ION | 52 |
| SRM | SIROHEME | 41 |
| CL | CHLORIDE ION | 40 |
| BVQ | NORPSEUDO-B12 | 38 |
| CDL | CARDIOLIPIN | 38 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 31 |
| B12 | COBALAMIN | 25 |
| NAmetal | SODIUM ION | 23 |
| ZNmetal | ZINC ION | 15 |
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 13 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 11 |
| LMG | 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE | 9 |